Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2009 - 2026)

Vertex Pharmaceuticals' Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$40.3 million for Q1 2026.

• On a quarterly basis, Exchange Rate Effect fell 232.13% year-over-year to -$40.3 million in Q1 2026; TTM through Mar 2026 was $20.1 million, a 474.29% increase from a year earlier, with the FY2025 full-year figure at $90.9 million, up 313.38% from the prior year.
• Exchange Rate Effect slipped to -$40.3 million in Q1 2026 per VRTX's latest filing, from $7.3 million in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $57.2 million in Q2 2025 and bottomed at -$47.3 million in Q4 2024.
• The 5-year median for Exchange Rate Effect is -$2.5 million (2024), against an average of $335294.1.
• Across the five-year window, Exchange Rate Effect sank 747.5% in 2022 and soared 2388.0% in 2025, its largest moves.
• Year by year, Exchange Rate Effect stood at $40.8 million in 2022, then plunged by 32.84% to $27.4 million in 2023, then tumbled by 272.63% to -$47.3 million in 2024, then jumped by 115.43% to $7.3 million in 2025, then tumbled by 652.05% to -$40.3 million in 2026.
• Per Business Quant, the three latest VRTX Exchange Rate Effect figures stand at -$40.3 million (Q1 2026), $7.3 million (Q4 2025), and -$4.1 million (Q3 2025).